Review Of Alzheimer's Medicines Calls For Tougher Continuation Rule

New Stories

• Medicines Australia seeks answers on AI in HTA process

  September 23, 2026 - - Latest News

• The prevention gap and inside Sally Panton's bet on cellular health

  September 23, 2026 - - Latest News

• Pfizer 'deeply disappointed' in response to PBAC refusing to move on price

  September 23, 2026 - - Latest News

• Lilly goes direct with a patient platform for its non-PBS medicines

  September 23, 2026 - - Latest News

• A 'multistakeholder' reference group to shadow agreement negotiations

  September 23, 2026 -

• If there is a productivity gain in the process, then it should be passed on

  September 22, 2026 - - Latest News

• Given the official use of AI, a cease and desist would not be unreasonable

  September 22, 2026 - - Latest News